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~ A  Prospective Evaluation of the Outpatient Initiation 
of Antlarrhylhmic Therapy for Supreventricular 
Tachyarthythmlas 
Roger J, Laham, Ma~k E. Jasephscn. Harvard MediCal School, Beth Israel 
Hospital, Boston, MA 
This study was designed to ievealigate the foa~ibil~end safety of the out- 
patient Initiation of antianhythmic therapy in Pts with Supraventrl~lar tash- 
yarfhythmlas (SVT). Pts with SVT that required treatment with antiarrhytmic 
drugs were eligible for enrollmeoL Pls with active coronary artery disease, 
previous MI, CHF, LVEF < 40%, ventri~tar tacl~yanttythmias, prolonged QT, 
end une~¢plalned syncope were excluded from the study. The starting dose 
was edministered and Pts were obsen~rd for 2 hours. Using transtelaphonic 
monitoring, ECG stripe were transmitted 2 hours after each dose and with 
any symptoms, Pts were followed for 1 month, An identical cohort, hospi- 
talized for the initiation of identical antiarrhythmi~ drugs, was identified and 
constituted the comDarison population, The study cohort consisted of 28 Pts 
413 men and 15 women). The mean age was 58 ~ 19 years (range 20-86 
years). 2 Pts ('/%) had mild systolic left venfricutsr dysfunction end 2 Pts 
(7%) had estabfialted coronary artery disease. 5 Pis 418%) had LVH. The 
index ar~ythmia was atrial fibrillation in 21 patients (75%). The entiarrhyth- 
mio drags used were amlodarone in 11 Pts (39%)° tiecalnide in 9 Pts (32%), 
sotalal in 4 Pts (14%), dlsopyramide in 3 Pts (11%), and procalnamlda in 1 
Pt (4=/0), On follow-up, the average minimal heart rate was 58 ~: 9 Bpm. Only 
2 patients had QT intewal prolongation which did not lead to discontinuation 
of therapy. Complete suppression of index arrhythmia was observed in 12 
patients 443%). Adverse events were seen in 2 (7%) Pts (5-beat vanfficular 
tachycerdia~nrenotrOpic in ompetence) and resolved with discontinuation 
of therapy. The comparison cohort consisted of 28 patients (15 men and 
13 women, mean age 62 :E 18 years, atrial fibrillation in 75% of Pts). The 
mean hospital stay was 3,2 :E 1.1 days. The mean hospital charges of the 
hospitalized patients were significantly higher than the outpatient population 
charges 4T~6,586 -v 2,190 vs $1,173 :E 1,912, p < 0,0001). Conclusion:This 
study demonstrates that the outpatient initiation of antiarrhythmic therapy for 
SVT may provide s safe and cheaper alternative to the hospitalization of 
these patients for that puq~ose. 
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~ Long-Term Fellow-Up in Patients With Medically 
~elraetory Atrial Fibrillation Treated W'dh 
Propafenone and S~talol 
Leonard I. Ganz, Julie B, ehea, Sharon C. Reimold, Catherine O, Centillion, 
Peter I_ Friedman, IEIliott M. Antman. Brigharn and Women's Hos/~ital, 
Boston, MA 
Between March 1985 and August 1991, 209 patients who had failed to 
respond to an average of two type IA antiarrhythmi¢ drugs for atrial tibfillalion 
or flutter 4AF) were enrolled in investigational protocols utilizing propatecone 
(PPFN) end sotolal (SOT). Their msan age was 62 years and meen ejection 
fraction was 58%. AF was paroxysmal in 49% and chronic in 51%. Structural 
heart disease was present in 85%; 15% were Ions fibdllators, A survey 
regarding vital stair,s, current medications, and rhythm status was conducted 
after a mean follow, up of 5,3 years (range, 2`8-9,0 yearn), To date, vi~ status 
is known in 144 patients 469%). Total mo~dity duflng follow-Up iS 11,5%. 
Cardiac dlythm and medication information is available on f13 patier~, 
Recurrent symptomstio AF (either ,'hronio or paroxysmal) is now present in 
80 patients (71%), 
Cunent Therapy Re~urmnt AF(n = 80) Sinus Rhythm (n = 33) 
PPFN or SOT 16 24 
Ar~odarone 5 7 
Warfarin 73 t3 
Permanent pacemakers were implanted in 7 patients prior to enrollment 
and in 2,3 since enrollment. Thus, in the Ior~toml follow-up of this cohort 
of medically ~ r y  AF patients: 1. Mortality is abo~ 2,2% per year. 2. 
AF recurs frequently ~ fre&lmeot with PPFN and SOT, 3, AKdarrhyth- 
mic therapy does not eliminate the use of Ior@term warfadn therapy. 4. 
Permanent ~cemakers are t~mn~y imp~ed ~n these pa~ents. 
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~ Clinical Significance of a Non-High*Risk Ischemic 
SPECT Scan Within 6 Months After FrCA 
Timothy M. Bate~an, James H. O'Keofe Jr., James R McGraw, C~rie 
~, BamharL Robert W. Ugon. Cardiovascular Consultants, RC., Mid 
America Heart InsfitOte, Kansas City, MO 
Nonischsmi¢ SPECT s,~-~s po~t PTCA w~dk,"t a Im'~ !i~!ih~:l for subse- 
quem cardiac events while extensively isehemic scans usually prompt further 
revasCularizatien. Currently, it is unknown whether pts with non-extensive re- 
VerSible perfusion defects (NERPDs [defined as < 1 of LAD or multivessel 
distribution iscbemia or abn, TI-20t lung uptake]) within the first 6 rues post- 
PTCA have a benign outcome as do pts with NERPDs and non-intervened 
CAD. TO evaluate this, we analyzed our experience with all such SPECT 
findings from 1989 to 1994. Of 697 pts with NERPDs _.< 6 mos post-PTCA 
(1% lost to follow.up): 81% were male; 58% had prior MI; 20% had prior 
CA~]G; 52% had angina and 90°/<= had single-vesSel d]sthbu~on ischemia. 
There were 51 hard events (14 c~ndtac deaths; 37 nonfatal MIs) during a 
mean f/u of 30 mos; freedom from events was ¢, = at one year, 93% at two 
years, and 92% at three yearn. The only significant correlate of a hard event 
was repeat PTCA (event rate 10.6% vs 5.3% for those treated me~cally). 
P|S treated with repeat PTCA (n = 291) were compared to those treated 
medically (n = 400): the only significant difference was that 58"1o f repeat 
PTCA pts had angina vs 48% of medically Ireated pts (p = 0.009). 
Conclusions: 1) PIS with NERPDs ~ 6 rues post-PTCA have a significant 
hard event rate over the next few years; 2) Pts who have events am not easily 
predicted by usual Clinical indices; and 3) Responding to a non-extensive 
reversible pertusion defect on SPECT by further PTCA doubles the hard 
event rate. 
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~ l*123Hodophenylpentadecanoic Acid (IPPA) 
Overestimates Myocardial Salvage Early After 
Reperfusion 
David K. Glover, Mirta Ruiz, Hiwot Desta, Dennis A. C, alnon, William 
H. Smith, Denny O. Watson, George A. Belier, University of Virginia, 
CharlotP..swlle, VA 
We have prcvious~ .~ho~'n IPPA to be supedor to T1-201 for assessing 
i~yocardial v;abii~ in a canine ~ Of sgSt~ined low flOW end systolic dys- 
function with minimal subendosardial necrosis. We now sought o determine 
the potential use of IPPA for assessing myocardial viability eady after roper- 
fusion (Rp), Accordingly, IPPA (5 mCi) was injected in 5 dog~ 60 rain alter 
Rp following 180 rain of total LAD occlusion (O¢c) and images were acquired 
over 2 hours. LAO Thickening fell from 21 to -3% (p < 0.01) during Occ and 
remained dyskine~c after Rp, Despite an infarct size averaging 50.6% of the 
dsk area (13,9% LV) them waS subslantial IPPA uptake seen on initial im- 
ages, LAD/LGX count ratios from background sul0~ected images were 0.64 
"4- 0.03 and 0.76 ~: 0.03 at 5 artd 120 rain respecSvely (p = NS). In addition, 
the transmurel LAD/LCX IPPA activity ra~o from post mortem gamma well 
counting (0,82) was not significantly different from the Rp LAD/LCX flow ratio 
when IPPA was injected (1.0). Even in the most severely ischami¢ segments 
(Oc¢ flow < 10% nom~al; n= 45), there was substentJal IPPA activity of 63,6% 
of normal suggesting sequestration of no~l i zed  Iracer. In summary, 
in this canine model of coronary Oct and Rp, e~,rly administration of IPPA 
resulted in an overestimation of the ~ of myocan~al salvage due to 
retentiOn of the tracer in infarcted regions. The mechenism for this prolonged 
retention remaln~ to be datem~ined. 
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~ Rekltion of Preoperative Ischemia Severity to 
A~ts~e/~Di~a~ Greffing In 2"vessel COronary 
Phyllis G. Supine, Clare Hod-.'ea~, DeboP~ A. Lauterstein, Ben A. D~i, 
,~flrey S. Borer. Comell ~ coerce, New York, IVY 
We have previously sP, ovm that ischenda severity, determined by change 
44) in LVEF Imm rest to exar~ex)  during ra~onLcJide cineangiography 
(~RNC, A), iS art i n ~  ~ of ~ events (CE) among reed'tally 
treated (MEO) 10ts ~ 2-veasal(v) oarena~y ane~ ¢~seese (CAD). HOwever. 
U~e beeatits ot com~ =te,y bypass ~dt~g4CABG) for th~ Ix~at~n(pop) 
